Related Experiment Video

Updated: Jul 11, 2026

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

[Drug-induced hypersensitivity due to phenytoin]

Seiko Itomi1, Akihisa Okumura, Taketo Ikuta

  • 1Department of Pediatrics, Nagoya First Red Cross Hospital, Nagoya, Aichi.

No to Hattatsu = Brain and Development
|September 21, 2007
PubMed

Insights

Boys are more prone to phenytoin hypersensitivity reactions than girls. Lower initial phenytoin serum levels, not dose or maximum levels, were linked to these adverse events in a study on drug hypersensitivity.

Area of Science:

  • Pharmacology
  • Clinical Toxicology
  • Immunology

Context:

  • Intravenous phenytoin is a critical anticonvulsant medication.
  • Hypersensitivity reactions pose a significant clinical challenge.
  • Understanding risk factors is crucial for patient safety.

Purpose:

  • To identify factors associated with intravenous phenytoin-induced hypersensitivity.
  • To analyze demographic and pharmacokinetic variables in phenytoin hypersensitivity.

Summary:

  • Hypersensitivity reactions to intravenous phenytoin were more frequent in boys (P < 0.05).
  • Lower initial phenytoin serum levels, not initial or maximum doses, correlated with hypersensitivity.
  • Total phenytoin dose was higher in hypersensitive patients, but this was not statistically significant.

Impact:

  • Findings aid in predicting and potentially preventing phenytoin hypersensitivity.
  • Highlights the importance of monitoring initial serum levels in pediatric patients.
  • Informs clinical practice regarding phenytoin administration and risk assessment.

More Related Videos

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats13:26

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats

Published on: July 19, 2007

Seizure Activity Induced by Electroshock in Drosophila Larvae06:10

Seizure Activity Induced by Electroshock in Drosophila Larvae

Published on: June 6, 2025

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...